Anti-CD81 antibodies reduce migration of activated T lymphocytes and attenuate mouse experimental colitis.

Sci Rep · 2020 · PMC7181603 · PMID 32332834

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The body weight change of mice with established TNBS-induced colitis treated with the anti-CD81 antibody did not reach statistical significance from day 0 to 7, but the body weight change from day 0 to 18 was increased significantly.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.